MPIC’s mWell attracts strong investor interest

Metro Pacific Investments Corp.’s (MPIC) digital health-care arm is attracting growing interest from investors, signaling rising confidence in telemedicine and integrated healthcare solutions.

In an interview, MPIC chief finance officer Chaye Cabal-Revilla said multiple investors have been eyeing the Manuel Pangilinan-led mWell, a tech-based health-care platform.

“A lot of investors have really been looking at mWell, even when we were exploring MPH (Metro Pacific Health) before,” Cabal-Revilla said. “They were saying they want to invest in MPH, and they want to include mWell as well.’”

The interest extends beyond traditional health-care investors. She said even non-MPH investors were evaluating mWell as a standalone opportunity, citing its global recognition and expanding role in digital health-care delivery.

Still, MPIC is taking a measured approach.

“We are in discussions, but we haven’t really committed to anyone yet,” she said, noting that the group is prioritizing operational improvements before bringing in partners.

Central to this effort is the integration of mWell with KonsultaMD, which MPIC acquired in May last year. The company is consolidating platforms to improve efficiency and reduce costs.

“We’re trying to optimize them and kill nonperforming ones to improve cost efficiency,” she said. “We are working toward having a unified doctor platform and a unified patient platform.”

Originally projected to take three years, the integration is now being accelerated to a year and a half, with the company nearing its first year of execution.

Beyond capital, MPIC is also exploring partnerships that can bring in technical expertise.

Cabal-Revilla said the company had been approached by overseas groups interested in white-labeling mWell in their respective markets, meaning they will run it under their own brand.

“But before we do that, we want to complete our backend integration to make expansion faster and more efficient,” she said.

The push comes as the Philippines continues to grapple with gaps in health-care access.

Cabal-Revilla cited data showing that six out of 10 Filipinos die without ever seeing a doctor, while doctor-to-patient ratios remain far below global standards. INQ

See Also

Ayala Land launches P10-B stock buyback program

She said mWell aims to help bridge this gap through digital tools such as teleconsultation, health IDs and portable “clinic in a bag” solutions that can be deployed in underserved areas.

“Everything the country needs in terms of health requirements is already within mWell,” she said.

Financially, the platform is nearing a turning point. Cabal-Revilla said mWell was already profitable last year on a standalone basis, although the inclusion of KMD resulted in a modest loss of less than P50 million for the full year.

“With KMD, we’re targeting [break-even] this year,” she said.

The company is also exploring opportunities to work with the government, including potential public-private partnerships, as it pushes for broader adoption of digital health solutions.

For MPIC, the strong investor interest underscores mWell’s potential—not just as a support platform for its healthcare network, but as a scalable digital health business in its own right.